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AMPK is a cellular energy sensor conserved across eukaryotes that in C. elegans prolongs life span and
mimics dietary restriction. Stenesen and colleagues (2012) activate AMPK both directly and indirectly by
altering AMPbiosynthesis to slow aging inDrosophila, highlighting AMPK as a conserved life spanmodulator
that links energy sensing to longevity.For an organism to survive, it must main-
tain energy homeostasis by tightly regu-
lating the balance between anabolic
processes that generate energy and cata-
bolic ones that eat into reserves. Fine-
tuning this balance becomes especially
critical when energy intake is low, leaving
cells without adequate supply to meet
demand. In such cases, organisms from
yeast to mammals avoid energy crisis by
implementing austerity measures, reallo-
cating limited resources from growth
and reproduction toward self-preserva-
tion and survival (Fontana et al., 2010).
Strikingly, animals in this thrifty state
show remarkable resistance to multiple
age-onset pathologies, including cancer,
metabolic disease, and neurodegenera-
tive disorders. In this issue of Cell Metab-
olism, Stenesen et al. (2012) use genetic
approaches to disrupt energy balance
and slow aging in the fruit fly Drosophila
melanogaster, reinforcing the idea that
energetics, metabolism and longevity are
tightly linked and that altering steady-
state energy levels may be a means to
treat age-related diseases.
To identify genes linking energy
homeostasis to longevity, Stenesen and
coworkers performed a two-pronged
forward genetics screen in Drosophila,
seeking mutations that both increased
life span and specifically affected genes
expressed in metabolically active tissues.
Of ten significantly long-lived fly mutants,
flies carrying mutations in the gene
encoding Adenylosuccinate Synthetase
(AdSS), a key metabolic enzyme involved
in the synthesis of adenosine monophos-
phate (AMP), showed the strongest
effects. AMP can be generated from
both de novo synthesis and salvage path-
ways and is a nucleotide precursor of
adenosine triphosphate (ATP), which
acts as the critical energy source formost cellular processes. Confirming
that the increase in longevity was not
specific to AdSS, Stenesen et al. tested
the life span of flies harboring mutants in
multiple genes involved in AMP biosyn-
thesis, and in each case they saw life
span extension.
To determine the effect these prolon-
gevity mutations were having on cellular
energetics, Stenesen et al. used high-per-
formance liquid chromatography (HPLC)
to measure AMP and ATP availability as
a readout of energy balance. Surprisingly,
despite disrupting AMP biosynthesis,
each long-lived mutant showed increases
in both total AMP and the ratio of
AMP::ATP, mimicking the effects of
energy depletion (Figure 1). Increases to
the AMP::ATP ratio are indicative of
energy imbalance, with more energy
being utilized than is produced. When
such imbalance is detected, cells attempt
to restore energy homeostasis by inhibit-
ing anabolic processes that use energy
and activating catabolic ones that pro-
duce it. In eukaryotes, the key orches-
trator of this homeostatic process is
AMP-activated protein kinase (AMPK),
which is activated by increased AMP::
ATP and as such acts as a cellular
fuel gauge (Hardie et al., 2012). AMPK is
activated during energy limiting condi-
tions known to extend life span, and its
dysregulation is associated with multiple
age-related diseases (Steinberg and
Kemp, 2009). As such, targeting AMPK
has been suggested as a means of reca-
pitulating the protective effects of energy
restriction (Fontana et al., 2010). How-
ever, to date the effect of AMPK activation
on survival has only been tested in the
nematode worm C. elegans, the result
being long lived animals that mimicked
those under energy stress despite being
well fed (Apfeld et al., 2004).Cell MetabolismStenesen et al. tested whether AMPK
was both necessary and sufficient for
the longevity effects of disrupted AMP
biosynthesis. As expected, given the rise
in AMP::ATP ratios, AMPK activity was
indeed increased in the long-lived flies.
Further, AMPK activation was required
for the longevity effects, as expressing
a dominant negative form of AMPK
completely suppressed the life span
increase of AdSS mutants. In a final tour
de force of fly genetics, Stenesen and
coworkers used a conditional gene switch
system to activate AMPK specifically
in metabolic tissues in adult flies. The re-
sulting AMPK gain-of-function animals
showed increases in life span comparable
to that of AdSS mutants, suggesting that
increased AMPK activity is sufficient for
the longevity effects of disruptions to
AMP biosynthesis pathways.
These data support the theory that tar-
geting AMPK might ameliorate diseases
of aging, but also raise further questions.
First, what are the identities of down-
stream mediators responsible for the
effects? Life span extension by activating
AMPK in C. elegans requires both activa-
tion of the FOXO transcription factor DAF-
16 (Greer et al., 2007) and inactivation of
the transcriptional coactivator CRTC-1
(Mair et al., 2011). Whether these AMPK
targets work together or separately to
mediate longevity remains unclear. Both
are well conserved in Drosophila and
humans, and testing their roles in
longevity will yield valuable insight.
That disruptions to pathways gener-
ating AMP results in increased AMP levels
is counterintuitive. Given that AMP can
be generated by de novo and salvage
pathways, and as a byproduct of the
conversion of ADP to ATP (2ADP #
AMP + ATP), it is possible that inhibiting
one branch of AMP biosynthesis feeds17, January 8, 2013 ª2013 Elsevier Inc. 5
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Figure 1. Tipping the Energy Balance: Mutations in AMP Biosynthesis Pathways Increase
the AMP::ATP Ratio to Increase Longevity
(A) Under normal conditions, de novo and salvage pathways are active, synthesizing AMP, which is con-
verted to ATP, resulting in a low AMP::ATP ratio and normal life span.
(B) Mutations in genes involved in AMP biosynthesis swing the energy balance to mimic a low-energy
state. AMP::ATP ratios are increased, promoting longevity via activation of AMPK.
Cell Metabolism
Previewsback to upregulate compensation in
another. How this results in an increase
in AMP::ATP ratios warrants further
investigation.
Ultimately the goal of the aging field is
to generate small molecules that promote
healthy aging in order to treat age-onset
disease, and here again the new data
raise interesting questions. Metformin is
the most widely prescribed treatment for
type II diabetes and a known potent acti-
vator of AMPK (Hardie et al., 2012). High
doses of Metformin have been shown to
increase life span in C. elegans in an
AMPK dependent manner (Onken and
Driscoll, 2010), yet recent data show that
this effect is not conserved in Drosophila
(Slack et al., 2012). That activating
AMPK can increase life span in fruit flies,6 Cell Metabolism 17, January 8, 2013 ª2013yet Metformin supplementation does
not, suggests that either feeding Metfor-
min does not activate AMPK in the rele-
vant tissues for life span extension in
Drosophila, or that off target effects of
Metformin might be limiting longevity in
spite of its effects on AMPK. Alternatively,
perhaps activating AMPK in all tissues in
Drosophila is detrimental to health. Ubiq-
uitous expression of the active AMPK
used by Stenesen et al. would determine
whether AMPK promotes longevity non-
cell autonomously when expressed in
one tissue or whether tissue-specific acti-
vation simply recapitulates a fraction of
what might be achievable if AMPK were
active in multiple tissue types.
The data of Stenesen et al. show that
AMPK can promote healthy aging inElsevier Inc.organisms beyond C. elegans. As such,
they add life span extension to the
growing list of conserved physiological
effects mediated by AMPK (Hardie et al.,
2012). The role of AMPK in sens-
ing resources and maintaining energy
balance is conserved from worm to fly to
mouse to humans. If the longevity data
presented by Stenesen et al. in this issue
represent the first step on a similar
conservation ladder, targeting AMPK to
tip the energy balance toward healthy
aging in humans might provide protection
against the ever-growing burden of age-
related pathologies.REFERENCES
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